Cell Res:“定制”转基因猪成为可能

2014-02-17 佚名 光明网

我国科学家成功培育出世界首例 ROSA26 定点基因打靶猪模型,这让科学家培养“定制”基因猪成为可能。研究成果日前在线发表于著名学术期刊《细胞研究》(Cell Research)上。这项研究是由吉林大学动物医院学院教授、中科院广州生物医药与健康研究院研究员赖良学博士与美国密西根大学王忠教授合作开展的。 赖良学解释说,从基因角度上看,猪与人类基因的相似性达到83%,因此猪在

我国科学家成功培育出世界首例 ROSA26 定点基因打靶猪模型,这让科学家培养“定制”基因猪成为可能。研究成果日前在线发表于著名学术期刊《细胞研究》(Cell Research)上。这项研究是由吉林大学动物医院学院教授、中科院广州生物医药与健康研究院研究员赖良学博士与美国密西根大学王忠教授合作开展的。



赖良学解释说,从基因角度上看,猪与人类基因的相似性达到83%,因此猪在医学研究上有很大前景。“比如,因为猪与人类生理比较接近,我们可以让猪得人类的疾病,进而探讨治疗方法,这比将小鼠作为模型动物要可靠得多。而猪的肝脏、胰脏等器官与人类的相似性也很高,科学家们一直在寻找将猪作为人源化器官培养体的方式。”赖良学说,“但这一切都需要通过转基因的方法实现。简单地说,就是破坏猪原有的一些性状,转进我们需要的性状。”

但是,由于缺乏猪胚胎干细胞,转基因猪的制备主要依赖于体细胞基因修饰和体细胞核移植技术。这种技术缺乏可控性,科学家们往往无法得到需要性状的猪,这成了目前研究中最大的瓶颈。

赖良学领导的研究团队在猪的基因组中找到了一个特殊基因位点: ROSA26 ,处在这个位点后的基因会广泛表达于所有组织和细胞中。“简单地说,这能让我们转入的基因表达出来,得到拥有定制性状的猪。”

这些“定制的猪”还可以用于在猪体内世系追踪各类干细胞的分化和再生,为揭示和人类干细胞相关的疾病机理和实施干细胞治疗提供宝贵的大动物实验依据。

原始出处:

Xiaoping Li, Yi Yang, Lei Bu, Xiaogang Guo, Chengcheng Tang, Jun Song, Nana Fan, Bentian Zhao, Zhen Ouyang, Zhaoming Liu, Yu Zhao, Xiaoling Yi, Longquan Quan, Songcai Liu, Zhenguo Yang, Hongsheng Ouyang, Y Eugene Chen, Zhong Wang & Liangxue Lai. Rosa26-targeted swine models for stable gene over-expression and Cre-mediated lineage tracing. Cell Research, 7 February 2014; doi:10.1038/cr.2014.15

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1868774, encodeId=d2761868e740f, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Nov 30 14:01:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037457, encodeId=bfab203e4579d, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sun Mar 16 05:01:00 CST 2014, time=2014-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959016, encodeId=b698195901677, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Mar 18 09:01:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471878, encodeId=bdc514e18782d, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555209, encodeId=2f0b155520962, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1868774, encodeId=d2761868e740f, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Nov 30 14:01:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037457, encodeId=bfab203e4579d, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sun Mar 16 05:01:00 CST 2014, time=2014-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959016, encodeId=b698195901677, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Mar 18 09:01:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471878, encodeId=bdc514e18782d, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555209, encodeId=2f0b155520962, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1868774, encodeId=d2761868e740f, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Nov 30 14:01:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037457, encodeId=bfab203e4579d, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sun Mar 16 05:01:00 CST 2014, time=2014-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959016, encodeId=b698195901677, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Mar 18 09:01:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471878, encodeId=bdc514e18782d, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555209, encodeId=2f0b155520962, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=)]
    2014-03-18 维他命
  4. [GetPortalCommentsPageByObjectIdResponse(id=1868774, encodeId=d2761868e740f, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Nov 30 14:01:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037457, encodeId=bfab203e4579d, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sun Mar 16 05:01:00 CST 2014, time=2014-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959016, encodeId=b698195901677, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Mar 18 09:01:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471878, encodeId=bdc514e18782d, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555209, encodeId=2f0b155520962, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1868774, encodeId=d2761868e740f, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Nov 30 14:01:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037457, encodeId=bfab203e4579d, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Sun Mar 16 05:01:00 CST 2014, time=2014-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959016, encodeId=b698195901677, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Mar 18 09:01:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471878, encodeId=bdc514e18782d, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555209, encodeId=2f0b155520962, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Wed Feb 19 03:01:00 CST 2014, time=2014-02-19, status=1, ipAttribution=)]
    2014-02-19 muzishouyi

相关资讯

英将测紫色转基因番茄汁益处 或能减缓癌症病程

英国科学家在加拿大种植了紫色的转基因番茄并榨成汁。这些紫色番茄汁将运回英国,科学家将测试其对于心脑血管的健康益处。 据英国多家媒体26日报道,英国科学家在加拿大种植的这批转基因番茄,共计可榨出约2000升紫色番茄汁。其中1200升近期将运抵英国诺维奇市,由约翰·英尼斯中心的科研人员进行一系列实验测试,并准备申请在英国市场上销售这种番茄汁。 据介绍,这种转基因番茄

袁隆平:转基因是未来发展方向 愿试吃转基因作物

袁隆平所带领的科研团队凭借“两系法杂交水稻技术研究与应用”获得2013年度国家科技进步奖特等奖,前段时间,由于支持转基因技术,这位老科学家被推到了舆论的风口浪尖。人民网记者就此对袁隆平进行了采访,他回应道:“转基因技术不能一概而论,转基因技术所属的分子发展技术,将成为未来农业技术的发展方向。” 转基因技术一直备受争议。袁隆平早先对媒体表态认为转基因是未来的发展方向,而被民众热议。关于转基因的

转基因考验中国媒体 并答崔永元先生的问候

·转基因食品安全在国际科学界有普遍的共识,中文反转基因的人没有一位分子生物学专家;·中国政府对转基因舆论并无政治立场和偏向,转基因安全与否是无关政治立场的科学问题;·转基因提供中国媒体证明自己有质量的机遇,中国媒体可以通过转基因问题提高基本水平。 毋庸讳言,中国的媒体和从业的媒体人恐怕普遍认为自己质量不高的一个重要原因是在重大事件上没有自由。 现在,转基因成为中文世界广

JCI:抗轮状病毒转基因水稻或可治疗轮状病毒腹泻感染

预计上市还等10年,可有效预防发展中国家儿童严重腹泻   研究人员在水稻基因组中添加了一种对抗轮状病毒的抗体。图片来源:IRRI   根据8月8日发表在《临床研究杂志》(J Clin Invest)上的一项研究成果,一种能够预防腹泻的转基因水稻为保护发展中国家的儿童提供了一条划算的途径。   通过在水稻基因组中添加一种最初在美洲驼中发现的能够抵

农业部闪电批准三种转基因大豆进口

日前,根据国家农业转基因生物安全委员会评审结果,农业部批准发放了巴斯夫农化有限公司申请的抗除草剂大豆CV127、孟山都远东有限公司申请的抗虫大豆MON87701和抗虫耐除草剂大豆MON87701×MON89788三个可进口用作加工原料的农业转基因生物安全证书。 据了解,抗除草剂大豆 CV127 已在美国、加拿大、日本、韩国、澳大利亚、新

中央一号文件流露中国对待转基因产业化态度

中国在其近日发布的中央一号文件中流露出当前对待转基因农产品的态度。 在中国,出于安全性考虑,人们对转基因农产品的生产和使用争议很大。 中央一号文件提出,“加强以分子育种为重点的基础研究和生物技术开发”。 这表明,中国支持在育种领域进行尖端生物技术研发。 分子育种基础研究和生物技术开发极具战略意义,其水平的高低,将关乎新的中国粮食安全战略的长期顺利实施。 中央一号文件提出,实施“以我为